Orphan designation: research and development
The European Medicines Agency provides support, including regulatory guidance and incentives, for the research and development of medicines for rare diseases in the European Union (EU).
Rare diseases
Sponsors of designated orphan medicines should also consider the regulatory information in the sections below: